Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 4:18 pm Sale | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | SUVRETTA CAPITAL MANAGEMENT LLC | 0 0.000% | -36,854,190 (Position Closed) | View |
| 2024-11-14 3:30 pm Sale | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Soleus Private Equity Fund III L.P. | 4,234,765 0.500% | -44,652,330 (-91.34%) | View |
| 2024-11-14 11:44 am Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | JANUS HENDERSON GROUP PLC JHG | 12,345,866 8.000% | 4,400,162 (+55.38%) | View |
| 2024-11-12 4:49 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Rock Springs Capital Management LP | 47,670,850 6.200% | 7,751,595 (+19.42%) | View |
| 2024-07-11 11:46 am Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | JANUS HENDERSON GROUP PLC JHG | 7,945,704 5.200% | 7,945,704 (New Position) | View |
| 2024-06-17 4:32 pm Purchase | 13D | MEREO BIOPHARMA GROUP PLC ADR MREO | Rubric Capital Management LP | 108,486,735 14.200% | 8,771,750 (+8.80%) | View |
| 2024-04-16 2:58 pm Purchase | 13D | MEREO BIOPHARMA GROUP PLC ADR MREO | Rubric Capital Management LP | 99,714,985 14.220% | 10,100 (+0.01%) | View |
| 2024-02-14 6:51 pm Sale | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | ORBIMED ADVISORS LLC | 0 0.000% | -10,378,591 (Position Closed) | View |
| 2024-02-14 2:11 pm Unchanged | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Rock Springs Capital Management LP | 39,919,255 5.690% | 0 (Unchanged) | View |
| 2024-02-14 2:10 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Rock Springs Capital Management LP | 39,919,255 6.380% | 8,694,770 (+27.85%) | View |
| 2024-02-14 12:36 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | MANGROVE PARTNERS IM LLC | 43,764,465 6.240% | 43,764,465 (New Position) | View |
| 2024-02-13 5:26 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | SUVRETTA CAPITAL MANAGEMENT LLC | 36,854,190 5.300% | 32,000 (+0.09%) | View |
| 2024-02-06 4:15 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Soleus Private Equity Fund III L.P. | 48,887,095 7.000% | 500,000 (+1.03%) | View |
| 2024-02-05 5:09 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | ADAGE CAPITAL PARTNERS GP L.L.C. | 50,250,000 7.170% | 50,250,000 (New Position) | View |
| 2023-11-20 08:45 am Purchase | 13D | MEREO BIOPHARMA GROUP PLC ADR MREO | Rubric Capital Management LP | 99,704,885 14.220% | 2,378,330 (+2.44%) | View |
| 2023-11-15 07:56 am Purchase | 13D | MEREO BIOPHARMA GROUP PLC ADR MREO | Rubric Capital Management LP | 97,326,555 13.880% | 7,200 (+0.01%) | View |
| 2023-11-13 07:31 am Purchase | 13D | MEREO BIOPHARMA GROUP PLC ADR MREO | Rubric Capital Management LP | 97,319,355 13.880% | 1,758,195 (+1.84%) | View |
| 2023-11-08 07:06 am Purchase | 13D | MEREO BIOPHARMA GROUP PLC ADR MREO | Rubric Capital Management LP | 95,561,160 13.630% | 2,188,575 (+2.34%) | View |
| 2023-11-06 07:30 am Purchase | 13D | MEREO BIOPHARMA GROUP PLC ADR MREO | Rubric Capital Management LP | 93,372,585 13.320% | 1,081,380 (+1.17%) | View |
| 2023-11-02 07:30 am Purchase | 13D | MEREO BIOPHARMA GROUP PLC ADR MREO | Rubric Capital Management LP | 92,291,205 13.250% | 92,130 (+0.10%) | View |